Figure 3 | Scientific Reports

Figure 3

From: RNA editing facilitates the enhanced production of neoantigens during the simultaneous administration of oxaliplatin and radiotherapy in colorectal cancer

Figure 3

ADAR1 and CCNI editing is promoted by chemotherapy, radiation, and CRT in HT29 cells. (A) ADAR1 expression levels and (B) CCNI RNA editing ratios in HT29 CRC cells treated with 5FU, CPT-11, OX, or control. (C) ADAR1 expression levels and (D) CCNI RNA editing ratios in HT29 CRC cells irradiated with 8 Gy, 16 Gy, or control. (E) ADAR1 expression levels and (F) CCNI RNA editing ratios in HT29 CRC cells treated with 5FU, CPT-11, or OX with radiation at 8 Gy or 16 Gy, or with the control. Wilcoxon’s signed-rank test. *p < 0.05, **p < 0.01, ***p < 0.001.

Back to article page